S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:SLGC

SomaLogic (SLGC) Stock Forecast, Price & News

$2.39
+0.03 (+1.27%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.33
$2.42
50-Day Range
$1.99
$2.45
52-Week Range
$1.92
$3.79
Volume
1.15 million shs
Average Volume
846,336 shs
Market Capitalization
$449.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.40

SomaLogic MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
125.9% Upside
$5.40 Price Target
Short Interest
Healthy
5.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.35mentions of SomaLogic in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.66) to ($0.59) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Business Services Sector

136th out of 317 stocks

Commercial Physical Research Industry

6th out of 14 stocks


SLGC stock logo

About SomaLogic (NASDAQ:SLGC) Stock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

SLGC Price History

SLGC Stock News Headlines

SomaLogic (NASDAQ:SLGC) Lowered to "Hold" at Canaccord Genuity Group
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
SomaLogic expands agreement with Novo Nordisk to 2025
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
More on SomaLogic
Why Shares of SomaLogic Are Up Tuesday
SomaLogic Reports Second Quarter 2023 Financial Results
SomaLogic CFO Shaun Blakeman Resigns
8-K: SomaLogic, Inc.
SomaLogic: Q1 Earnings Insights
See More Headlines
Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter.

SLGC Company Calendar

Last Earnings
8/14/2023
Today
10/01/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:SLGC
Fax
N/A
Employees
451
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.40
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+125.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-109,160,000.00
Net Margins
-139.23%
Pretax Margin
-139.94%

Debt

Sales & Book Value

Annual Sales
$101.39 million
Book Value
$3.00 per share

Miscellaneous

Free Float
160,049,000
Market Cap
$449.49 million
Optionable
Not Optionable
Beta
1.67
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Stephen A. Williams BS (Age 63)
    MB, Ph.D., Chief Medical Officer
    Comp: $648.03k
  • Mr. Adam Taich (Age 48)
    Interim CEO
  • Mr. Eliot M. Lurier CPA (Age 65)
    CPA, Interim Chief Financial Officer
  • Mr. Pi Zheng (Age 50)
    Interim Chief Accounting Officer
  • Dr. Jason Cleveland Ph.D.
    Chief Technology Officer
  • Dr. Nebojsa Janjic Ph.D. (Age 62)
    Chief Science Officer
  • Mr. Ruben Gutierrez J.D. (Age 48)
    Gen. Counsel
  • Ms. Alison Marie Roelke (Age 48)
    Chief People Officer













SLGC Stock - Frequently Asked Questions

Should I buy or sell SomaLogic stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SomaLogic in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SLGC shares.
View SLGC analyst ratings
or view top-rated stocks.

What is SomaLogic's stock price forecast for 2023?

4 equities research analysts have issued 12-month target prices for SomaLogic's shares. Their SLGC share price forecasts range from $2.50 to $8.00. On average, they anticipate the company's share price to reach $5.40 in the next twelve months. This suggests a possible upside of 125.9% from the stock's current price.
View analysts price targets for SLGC
or view top-rated stocks among Wall Street analysts.

How have SLGC shares performed in 2023?

SomaLogic's stock was trading at $2.51 at the beginning of 2023. Since then, SLGC stock has decreased by 4.8% and is now trading at $2.39.
View the best growth stocks for 2023 here
.

Are investors shorting SomaLogic?

SomaLogic saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 8,450,000 shares, a drop of 16.4% from the August 31st total of 10,110,000 shares. Based on an average daily trading volume, of 931,800 shares, the short-interest ratio is presently 9.1 days. Currently, 5.6% of the shares of the stock are sold short.
View SomaLogic's Short Interest
.

When is SomaLogic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our SLGC earnings forecast
.

How were SomaLogic's earnings last quarter?

SomaLogic, Inc. (NASDAQ:SLGC) issued its quarterly earnings results on Monday, August, 14th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.05. The firm had revenue of $20.47 million for the quarter, compared to analyst estimates of $19.50 million. SomaLogic had a negative net margin of 139.23% and a negative trailing twelve-month return on equity of 25.49%.

What ETF holds SomaLogic's stock ?

ARK Genomic Revolution ETF holds 13,104,112 shares of SLGC stock, representing 1.22% of its portfolio.

What guidance has SomaLogic issued on next quarter's earnings?

SomaLogic updated its FY 2023 earnings guidance on Monday, August, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $80.00 million-$84.00 million, compared to the consensus revenue estimate of $81.62 million.

What is SomaLogic's stock symbol?

SomaLogic trades on the NASDAQ under the ticker symbol "SLGC."

How do I buy shares of SomaLogic?

Shares of SLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SomaLogic's stock price today?

One share of SLGC stock can currently be purchased for approximately $2.39.

How much money does SomaLogic make?

SomaLogic (NASDAQ:SLGC) has a market capitalization of $449.49 million and generates $101.39 million in revenue each year. The company earns $-109,160,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

How many employees does SomaLogic have?

The company employs 451 workers across the globe.

How can I contact SomaLogic?

SomaLogic's mailing address is 667 MADISON AVENUE, NEW YORK NY, 10065. The official website for the company is ii.cmlifesciencesspac.com. The company can be reached via phone at 303-625-9000 or via email at investors@somalogic.com.

This page (NASDAQ:SLGC) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -